Clinical Trial Update: A Study of Chiglitazar in Patients With Metabolic Dysfunction-associated Steatohepatitis and Type 2 Diabetes Mellitus [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating Chiglitazar in patients with metabolic dysfunction-associated steatohepatitis and type 2 diabetes mellitus; the study statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Dysfunction-associated Steatohepatitis
• Type 2 Diabetes Mellitus

Drugs mentioned

• Chiglitazar (Chiglitazar)

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: MASH - Metabolic Dysfunction-Associated Steatohepatitis, T2DM (Type 2 Diabetes Mellitus) | Phase 2 | Status: NOT_YET_RECRUITING